Brain neuroprotection by scavenging blood glutamate

Experimental Neurology

Volumn 203, Issue 1, 2007, Pages 213-220

  Zlotnik, Alexander ^a   Gurevich, Boris ^a   Tkachov, Sergei ^a   Maoz, Ilana ^b   Shapira, Yoram ^a   Teichberg, Vivian I ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Acute brain neurodegeneration; Blood glutamate scavenging; Brain glutamate levels; Closed head injury; Glutamate oxaloacetate transaminase; Neurological severity score; Neuroprotection; Oxaloacetate; Spontaneous recovery

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GLUTAMIC ACID; OXALOACETIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN PROTECTION; CONTROLLED STUDY; DRUG DOSE REDUCTION; HEAD INJURY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC; BRAIN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SYNERGISM; GLUTAMIC ACID; INJECTIONS, INTRAVENOUS; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXALOACETATE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 33751417383     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.08.021     Document Type: Article

References (48)

1. Alves O.L., Bullock R., Clausen T., Reinert M., and Reeves T.M. Concurrent monitoring of cerebral electrophysiology and metabolism after traumatic brain injury: an experimental and clinical study. J. Neurotrauma 22 (2005) 733-749
2. Baker A.J., Moulton R.J., MacMillan V.H., and Shedden P.M. Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J. Neurosurg. 79 (1993) 369-372
3. Barzo P., Marmarou A., Fatouros P., Corwin F., and Dunbar J. Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury. J. Neurosurg. 85 (1996) 1113-1121
4. Berl S., Lajtha A., and Waelsch H. Amino acid and protein metabolism-VI cerebral compartments of glutamic acid metabolism. J. Neurochem. 7 (1961) 186-197
5. Biegon A., Fry P.A., Paden C.M., Alexandrovich A., Tsenter J., and Shohami E. Dynamic changes in N-methyl-d-aspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive deficits. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5117-5122
6. Bullock R., Zauner A., Woodward J.J., Myseros J., Choi S.C., Ward J.D., Marmarou A., and Young H.F. Factors affecting excitatory amino acid release following severe human head injury. J. Neurosurg. 89 (1998) 507-518
7. Burckhardt B.C., Lorenz J., Kobbe C., and Burckhardt G. Substrate specificity of the human renal sodium dicarboxylate cotransporter, hNaDC-3, under voltage-clamp conditions. Am. J. Physiol.: Renal. Physiol. 288 (2005) F792-F799
8. Castillo J., Davalos A., Naveiro J., and Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 27 (1996) 1060-1065
9. Castillo J., Davalos A., and Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet. 349 (1997) 79-83
10. Castillo J., Davalos A., Alvarez-Sabin J., Pumar J.M., Leira R., Silva Y., Montaner J., and Kase C.S. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 58 (2002) 624-629
11. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
12. Desagher S., Glowinski J., and Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17 (1997) 9060-9067
13. Faden A.I., Demediuk P., Panter S.S., and Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244 (1989) 798-800
14. Farooque M., Hillered L., Holtz A., and Olsson Y. Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: an experimental study in the rat using microdialysis. J. Neurotrauma 13 (1996) 537-548
15. Ferrarese C., Aliprandi A., Tremolizzo L., Stanzani L., De Micheli A., Dolara A., and Frattola L. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57 (2001) 671-675
16. Furukawa T., Hoshino S., Kobayashi S., Asakura T., Takahashi M., Atsumi T., and Teramoto A. The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats. J. Neurotrauma 20 (2003) 269-278
17. Gottlieb M., Wang Y., and Teichberg V.I. Blood-mediated scavenging of cerebrospinal fluid glutamate. J. Neurochem. 87 (2003) 119-126
18. Graham Jr. L.T., and Aprison M.H. Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods. Anal. Biochem. 15 (1966) 487-497
19. Guyot L.L., Diaz F.G., O'Regan M.H., McLeod S., Park H., and Phillis J.W. Real-time measurement of glutamate release from the ischemic penumbra of the rat cerebral cortex using a focal middle cerebral artery occlusion model. Neurosci. Lett. 299 (2001) 37-40
20. Hosoya K., Sugawara M., Asaba H., and Terasaki T. Blood-brain barrier produces significant efflux of l-aspartic acid but not d-aspartic acid: in vivo evidence using the brain efflux index method. J. Neurochem. 73 (1999) 1206-1211
21. Ikonomidou C., and Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurol. 1 (2002) 383-386
22. Johnston M.V., Trescher W.H., Ishida A., and Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49 (2001) 735-741
23. Koura S.S., Doppenberg E.M., Marmarou A., Choi S., Young H.F., and Bullock R. Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir., Suppl. 71 (1998) 244-246
24. Margaill I., Parmentier S., Callebert J., Allix M., Boulu R.G., and Plotkine M. Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats. J. Cereb. Blood Flow Metab. 16 (1996) 107-113
25. O'Kane R.L., Martinez-Lopez I., DeJoseph M.R., Vina J.R., and Hawkins R.A. Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J. Biol. Chem. 274 (1999) 31891-31895
26. Pajor A.M., Gangula R., and Yao X. Cloning and functional characterization of a high-affinity Na(+)/dicarboxylate cotransporter from mouse brain. Am. J. Physiol.: Cell Physiol. 280 (2001) C1215-C1223
27. Palmer A.M., Marion D.W., Botscheller M.L., Swedlow P.E., Styren S.D., and DeKosky S.T. Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J. Neurochem. 61 (1993) 2015-2024
28. Phillis J.W., Smith-Barbour M., and O'Regan M.H. Changes in extracellular amino acid neurotransmitters and purines during and following ischemias of different durations in the rat cerebral cortex. Neurochem. Int. 29 (1996) 115-120
29. Richards D.A., Tolias C.M., Sgouros S., and Bowery N.G. Extracellular glutamine to glutamate ratio may predict outcome in the injured brain: a clinical microdialysis study in children. Pharmacol. Res. 48 (2003) 101-109
30. Ronne Engstrom E., Hillered L., Enblad P., and Karlsson T. Cerebral interstitial levels of glutamate and glutamine after intravenous administration of nutritional amino acids in neurointensive care patients. Neurosci. Lett. 384 (2005) 7-10
31. Rose M.E., Huerbin M.B., Melick J., Marion D.W., Palmer A.M., Schiding J.K., Kochanek P.M., and Graham S.H. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 943 (2002) 15-22
32. Sattler R., and Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24 (2001) 107-129
33. Serena J., Leira R., Castillo J., Pumar J.M., Castellanos M., and Davalos A. Neurological deterioration in acute lacunar infarctions: the role of excitatory and inhibitory neurotransmitters. Stroke 32 (2001) 1154-1161
34. Shapira Y., Shohami E., Sidi A., Soffer D., Freeman S., and Cotev S. Experimental closed head injury in rats: mechanical, pathophysiologic, and neurologic properties. Crit. Care Med. 16 (1988) 258-265
35. Shapira Y., Artru A.A., and Lam A.M. Ketamine decreases cerebral infarct volume and improves neurological outcome following experimental head trauma in rats. J. Neurosurg. Anesthesiol. 4 (1992) 231-240
36. Shaw P.J., Forrest V., Ince P.G., Richardson J.P., and Wastell H.J. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4 (1995) 209-216
37. Singh I.N., Sullivan P.G., Deng Y., Mbye L.H., and Hall E.D. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J. Cereb. Blood Flow Metab. (2006) (Electronic publication ahead of print)
38. Smith Q.R. Transport of glutamate and other amino acids at the blood-brain barrier. J. Nutr. 130 (2000) 1016S-1022S
39. Spranger M., Krempien S., Schwab S., Maiwald M., Bruno K., and Hacke W. Excess glutamate in the cerebrospinal fluid in bacterial meningitis. J. Neurol. Sci. 143 (1996) 126-131
40. Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P.F., Le Forestier N., Marouan A., Dib M., and Meininger V. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J. Neurol. Sci. 193 (2002) 73-78
41. Stoffel M., Plesnila N., Eriskat J., Furst M., and Baethmann A. Release of excitatory amino acids in the penumbra of a focal cortical necrosis. J. Neurotrauma 19 (2002) 467-477
42. Takamatsu H., Kondo K., Ikeda Y., and Umemura K. Hydroxyl radical generation after the third hour following ischemia contributes to brain damage. Eur. J. Pharmacol. 352 (1998) 165-169
43. Vespa P., Prins M., Ronne-Engstrom E., Caron M., Shalmon E., Hovda D.A., Martin N.A., and Becker D.P. Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. J. Neurosurg. 89 (1998) 971-982
44. Westergren I., and Johansson B.B. NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema. Brain Res. 573 (1992) 324-326
45. Westergren I., and Johansson B.B. Blockade of AMPA receptors reduces brain edema following opening of the blood-brain barrier. J. Cereb. Blood Flow Metab. 13 (1993) 603-608
46. Xiong Y., Shie F.S., Zhang J., Lee C.P., and Ho Y.S. Prevention of mitochondrial dysfunction in post-traumatic mouse brain by superoxide dismutase. J. Neurochem. 95 (2005) 732-744
47. Zauner A., Bullock R., Kuta A.J., Woodward J., and Young H.F. Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir. Suppl. 67 (1996) 40-44
48. Zhang H., Zhang X., Zhang T., and Chen L. Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries. Clin. Chem. 47 (2001) 1458-1462